Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 456

Results For "ABLE"

5256 News Found

J&J booster after the two-dose Pfizer-BioNTech vaccine increases antibody and T-cell responses
News | December 06, 2021

J&J booster after the two-dose Pfizer-BioNTech vaccine increases antibody and T-cell responses

These results demonstrate the potential benefits of heterologous boosting (mix-and-match). The article describing these results have been posted on medRxiv


Narayana Hrudayalaya to open a hospital in Punjab
Hospitals | December 05, 2021

Narayana Hrudayalaya to open a hospital in Punjab

The hospital is scheduled to open in 2024 with a bed capacity of 225


Morpen gets U.S. FDA approval for Fexofinadine
Drug Approval | December 05, 2021

Morpen gets U.S. FDA approval for Fexofinadine

Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever


Apollo Health Ventures closes US $ 180 million fund
Startup | December 05, 2021

Apollo Health Ventures closes US $ 180 million fund

The fund aims at investing in companies that extends human healthspan


Neuberg Diagnostics expands to North India
Clinical Trials | December 03, 2021

Neuberg Diagnostics expands to North India

Collectively, these 10 laboratories are capable of processing about 10,000 samples in a day and deliver results within the given turnaround time


Over one lakh SARS-CoV-2 genomes sequenced till November
Policy | December 03, 2021

Over one lakh SARS-CoV-2 genomes sequenced till November

Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry


Unichem Labs gets ANDA approval for schizophrenia medicine
Drug Approval | December 03, 2021

Unichem Labs gets ANDA approval for schizophrenia medicine

The product will be commercialized from Unichem's Ghaziabad plant


Biocon Pharma receives ANDA approval for Mycophenolic acid
Drug Approval | December 03, 2021

Biocon Pharma receives ANDA approval for Mycophenolic acid

This further adds to Biocon’s portfolio of vertically integrated complex drug products


North America accounts for 50 % of generic pharma market
News | December 03, 2021

North America accounts for 50 % of generic pharma market

Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively


Booster dose  for those above 40
News | December 03, 2021

Booster dose for those above 40

The recommendation was made by the Indian SARS-CoV-2 Genomics Sequencing Consortium (INSACOG), a network of national testing labs set up by the government to monitor genomic variations of Covid-19